(Q46271859)

21 December 2017

title

The cost of adjuvant chemotherapy in patients with early-stage breast carcinoma (English)

1 reference

21 December 2017

1 reference

3

1 reference

21 December 2017

David L Veenstra

5

object named as

David L Veenstra

1 reference

21 December 2017

author name string

Nina Oestreicher

1

1 reference

21 December 2017

Scott D Ramsey

2

1 reference

21 December 2017

Hannah M Linden

4

1 reference

21 December 2017

language of work or name

English

0 references

publication date

1 November 2005

1 reference

21 December 2017

published in

Cancer

1 reference

21 December 2017

volume

104

1 reference

21 December 2017

issue

10

1 reference

21 December 2017

page(s)

2054-2062

1 reference

21 December 2017

Discrepancy between consensus recommendations and actual community use of adjuvant chemotherapy in women with breast cancer

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21464

Trends in use of adjuvant multi-agent chemotherapy and tamoxifen for breast cancer in the United States: 1975-1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21464

National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21464

7 January 2021

Adjuvant therapy for breast cancer: practice patterns of community physicians

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21464

7 January 2021

Gene expression profiling and breast cancer care: what are the potential benefits and policy implications?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21464

7 January 2021

Costs of treatment for elderly women with early-stage breast cancer in fee-for-service settings

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21464

7 January 2021

Stage, age, comorbidity, and direct costs of colon, prostate, and breast cancer care

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21464

7 January 2021

Cost comparison of mastectomy versus breast-conserving therapy for early-stage breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21464

7 January 2021

Benefits and costs of screening and treatment for early breast cancer. Development of a basic benefit package

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21464

7 January 2021

Medicare payments from diagnosis to death for elderly cancer patients by stage at diagnosis.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21464

7 January 2021

Treatment costs of adjuvant cytotoxic therapy in premenopausal breast cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21464

7 January 2021

Comparison of costs for infusion versus bolus chemotherapy administration--Part two. Use of charges versus reimbursement for cost basis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21464

7 January 2021

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21464

7 January 2021

Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21464

7 January 2021

Estimating the costs attributable to a disease with application to ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21464

7 January 2021

Estimating medical costs from incomplete follow-up data

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21464

7 January 2021

A gene-expression signature as a predictor of survival in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21464

7 January 2021

Identifiers

DOI

10.1002/CNCR.21464

1 reference

21 December 2017

1 reference

21 December 2017